Big news: our prices just got a lot lower. Shop now|New here? Get up to $200 in welcome perks, valid for 14 days. Claim offer now
US shipping INCLUDED on orders above $200
Research Insights

All content and product details on this site are for educational purposes only. Products are for in-vitro studies (performed outside the body) and not FDA-approved for medical use. Any introduction into humans or animals is prohibited by law.

Thymalin: Thymic Peptide Regulation in Immune Research

Nabiha Khalid
October 27, 2026
Thymalin: Thymic Peptide Regulation in Immune Research

Brief Overview/Summary

Explore research on Thymalin peptide in immune regulation and T-cell development through scientific studies.

Thymalin is a polypeptide complex isolated from calf thymus by mild acid extraction [1]. It is associated with the work of Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology [2]. The complex is a mixture of peptides, and one of its immunomodulatory components, the dipeptide L-Glu-L-Trp, has been isolated from it by reversed-phase high-performance liquid chromatography [1][3]. The effects of Thymalin on the differentiation and activation of immune cells have been examined in laboratory studies [1][2].

Thymalin research grew out of work on low-molecular-weight polypeptide factors obtained from bovine thymus, which were studied in mice for their effects on immune responses, tumour incidence and lifespan [4][5]. Peptides of this group have been characterised by Prof. Khavinson's laboratory since 1973, and were initially isolated from animal tissues [6].

Thymalin has been examined for immune-modulating properties, with studies measuring T-lymphocyte differentiation and cytokine production [1][2]. Its proposed mechanism involves the maturation of T cells, a component of adaptive immunity [2].

Studies of Thymalin have focused on thymic function, the regulation of immunological responses and T-cell differentiation. In cell-culture studies it has also been examined for effects on inflammatory signalling [6].

Mechanism of Action of Thymalin Peptide

Immune-cell differentiation has been studied in relation to Thymalin. In cultures of human hematopoietic stem cells, thymalin reduced the expression of the stem-cell marker CD44 and of CD117, a marker of an intermediate stage of differentiation, two- to three-fold, and increased the expression of CD28, a marker of mature T lymphocytes, 6.8-fold; the authors interpreted this as stimulation of differentiation towards mature T cells [2].

Natural thymic peptides and the synthetic L-Glu-L-Trp dipeptide derived from thymalin have been reported to activate T-cell differentiation and T-cell recognition of peptide–MHC complexes, and to change intracellular cyclic nucleotide levels and the release of interleukin-2 and interferon by lymphocytes [1][3].

In the human monocytic THP-1 cell line, thymalin was one of five peptide preparations that increased tyrosine phosphorylation of mitogen-activated kinases and inhibited lipopolysaccharide-stimulated production of TNF and IL-6 by differentiated cells; the peptides also reduced adhesion of these cells to activated endothelial cells [6].

The effects of Thymalin on immune regulation examined in published studies place it among the more specialized immune system peptides, particularly in research on T-lymphocyte development and immune cell activity. Thymic peptide preparations have also been examined in aging biology research [5][7].

Research Evidence

Research on thymic peptide preparations in animals dates back several decades. In adult CBA mice, low-molecular-weight polypeptide factors from bovine thymus enhanced the rejection of skin allografts and stimulated the antibody response to sheep erythrocytes, and in female C3H/Sn mice, chronic exposure decreased spontaneous tumour development and prolonged lifespan [4].

In female SHR mice, thymus-derived polypeptide factors increased lifespan when exposure began in young animals but not in middle-aged animals, and decreased overall tumour and mammary adenocarcinoma incidence in young animals [5]. The L-Glu-L-Trp dipeptide isolated from thymalin has been studied separately: in female rats it was associated with a lower aging rate estimated from the Gompertz equation, longer survival of the longest-lived animals and lower spontaneous tumour incidence [3].

In immunological research, Thymalin is used to investigate T-cell differentiation and cytokine control [1][2]. In gerontology, thymic peptides have been examined in animal models of aging for effects on lifespan, tumour incidence and immune measures [4][5][7].

Research projects make comparisons between Thymalin and other thymic peptides, such as the synthetic dipeptides derived from it, and between natural and synthetic preparations [1][6]. Research methodologies include animal models and in vitro assays with stem cells, lymphocytes and monocytic cell lines [2][4][6].

Future Perspective

Investigations of Thymalin continue to centre on the control of T-cell differentiation and cytokine production [2][6]. One of the gaps is the lack of information regarding the targeted molecular mechanism of its biological activity, which the authors of recent work note requires further study [2].

Further research would be required to characterise the contributions of Thymalin's individual peptide components. Future research may examine thymic peptides in studies of age-associated immunological changes and of immune-cell differentiation [2][7].

References

  1. Morozov, V. G., & Khavinson, V. K. (1997). Natural and synthetic thymic peptides as therapeutics for immune dysfunction. International Journal of Immunopharmacology, 19(9-10), 501-505. https://doi.org/10.1016/s0192-0561(97)00058-1

  2. Khavinson, V. K., Linkova, N. S., Kvetnoy, I. M., Polyakova, V. O., Drobintseva, A. O., Kvetnaia, T. V., & Ivko, O. M. (2020). Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. Bulletin of Experimental Biology and Medicine, 170(1), 118-122. https://doi.org/10.1007/s10517-020-05016-z

  3. Anisimov, V. N., Khavinson, V. K., & Morozov, V. G. (2000). Immunomodulatory synthetic dipeptide L-Glu-L-Trp slows down aging and inhibits spontaneous carcinogenesis in rats. Biogerontology, 1(1), 55-59. https://doi.org/10.1023/a:1010042008969

  4. Anisimov, V. N., Khavinson, V. K., & Morozov, V. G. (1982). Carcinogenesis and aging. IV. Effect of low-molecular-weight factors of thymus, pineal gland and anterior hypothalamus on immunity, tumor incidence and life span of C3H/Sn mice. Mechanisms of Ageing and Development, 19(3), 245-258. https://doi.org/10.1016/0047-6374(82)90057-4

  5. Anisimov, V. N., Loktionov, A. S., Khavinson, V. K., & Morozov, V. G. (1989). Effect of low-molecular-weight factors of thymus and pineal gland on life span and spontaneous tumour development in female mice of different age. Mechanisms of Ageing and Development, 49(3), 245-257. https://doi.org/10.1016/0047-6374(89)90075-4

  6. Avolio, F., Martinotti, S., Khavinson, V. K., Esposito, J. E., Giambuzzi, G., Marino, A., ... & Toniato, E. (2022). Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International Journal of Molecular Sciences, 23(7), 3607. https://doi.org/10.3390/ijms23073607

  7. Anisimov, V. N., & Khavinson, V. K. (2010). Peptide bioregulation of aging: results and prospects. Biogerontology, 11(2), 139-149. https://doi.org/10.1007/s10522-009-9249-8

Read more about peptides